SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?


To: valueminded who wrote (25068)12/12/1997 10:18:00 AM
From: Skeeter Bug  Read Replies (2) | Respond to of 132070
 
>>I love the way that estimates are quietly moved down w/o notifying the general
public.<<

chris, right on. dram ticks up 1% and its all over the news as a recovery. dram prices tank 50% and it takes a whining appleton on cnbc to really bring it public.

anyway, mu will trade at $16. it just isn't yet. maybe jan or feb. they release what i believe will be a loss next week. i will be sure to own puts ahead of the "news..." :-)



To: valueminded who wrote (25068)1/5/1998 3:57:00 PM
From: Knighty Tin  Respond to of 132070
 
Chris, I agree that Micron is cheap if any of those estimates were reality based and if they actually made free cash flow, which they have never done. When you have free cash flow, you don't eliminate dividends, sell profitable (until recently) subs, and sucker some folks into a goofus convert to raise cash. EPS is an accounting fiction. Free cash flow is a real figure and MU never had it, never will.

I think GTW is dead meat. They make overpriced and crummy computers. They do have good ads and investors seem to buy them because they are spunky. As Lou Grant told Mary Richards, "I hate spunk." Actually, I love spunk, but there has to be some steak with the sizzle and GTW doesn't have it. No way they compete with the big boys in a price-driven market.

I hate lots of banks, chiefly Wells Fargo and Sh, er, Citibank. Talk about eps accounting being totally fiction.

Some of the big dopers are overpriced. Merck and Warner-Lambert, one a great co. and one a lucky co., are priced way beyond their scanty research pipelines.

The Vegas hotels are a disaster waiting to happen. Buy the gun runners, IGT, Betm, etc, and sell the combatants, mainly anything with Trump attached and Mirage.

MB